A study is currently underway at King’s College London that will look at whether a mouth spray containing cannabinoids could be used to reduce symptoms of agitation and aggression in a small group of people with Alzheimer’s disease.
A few small clinical trials have assessed the effects of cannabinoids (including THC and synthetic cannabinoids, such as nabilone) on behavioural symptoms of dementia. However, trials and studies so far have generally been small or low quality making it difficult to come to a conclusion.
Alzheimer’s Society has never funded research into cannabis and dementia risk, or into cannabis as a potential treatment for dementia symptoms.
Tackling the symptoms of dementia
Cannabidiol or CBD does not cause any psychoactive or intoxicating effects.
Whilst the studies in the laboratory show some promise, we need to understand the wider effects that these components have before we can know whether they have any effect – positive or negative – on the development of Alzheimer’s in people.
Another study that gave both THC and CBD oil to mice with symptoms of Alzheimer’s disease showed an improved in learning and had less evidence of amyloid clumps in their bodies.
Products containing more than 0.2% THC are not legally available in the UK.
While this information gives us much hope in the fight against dementia, know that only small clinical trials have been conducted to determine the effects of CBD on dementia, making it difficult to come to a scientific conclusion. However, scientists are continuing to conduct rese arch to help further our ability to help those with dementia.
As dementia progresses, brain tissue actually dies and function is lost for good. This process can take time or it can happen very rapidly. In some trials, CBD showed promising results to help stop or even reverse the loss of brain function and memory loss in dementia patients. Additionally, CBED may help stimulate the brain to help keep connections within the brain and help seniors potentially delay the effects of dementia.
There is still much we do not know when it comes to CBD and its effectiveness in treating the symptoms of dementia. However, we are hopeful that new research and medications will be developed that will end dementia for good!
Because of how dementia affects the brain, a senior may become agitated or anxious in everyday situations. Sometimes this agitation can even turn vio lent. But remember that these behavior changes are caused by the disease and are not your loved one’s fault. CBD may be able to help alleviate these symptoms .
However, this applies to pure CBD. There are some retailers who produce CBD products with other ingredients or strains of CBD that have been tainted with other substances. Some companies also misrepresent their products and place different packaging labels on the products. This could pose a risk for your loved one, so i t’s important for you to obtain any CBD products through a company that has been approved by a third-party , meaning the products have been tested independently for quality.
Additionally, Dementia Care Central indicates that CBD may also help:
CBD is commonly used to help with anxiety, insomnia, poor sleep, and even pain relief. B ecause CBD has shown to help reduce anxiety and agitation, it is believed that it can help reduce these symptoms in seniors with dementia.
In clinical trials, researchers have found that the endocannabinoid system is involved in neurotransmission, neuropathology, and neurobiology of different forms of dementia, including Alzheimer’s Disease.
Scientists suggest that Parkinson’s disease may derive from lowered dopamine production and is most commonly expressed by muscular strains, tremors, and slow, flawed movement.
If you want a product that will give you more CBD and offer consistent dosing, you may go for CBDPure softgels. Each capsule comes with 25 mg of full-spectrum cannabidiol.
1. Alzheimer’s Disease
Sativex has equal amounts of THC and CBD. Hemp-derived CBD oil contains only 0.3% THC and there are no trials that would look into the effects of this cannabis solution on dementia.
A study conducted in 2014 found that higher concentrations of CBD may be required until the effects take hold. The study was conducted on transgenic mice.
Research shows a clear link between CBD and the reduction of inflammation and brain cell decline.
A 2016 study conducted by the National Institute of Health (NIH) found that activating cannabinoid receptors in the brain promoted the recovery of blood flow to the brain.